CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
81 hedge funds and large institutions have $428M invested in Crescent Biopharma, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 12 closing their positions.
Holders
81
Holders Change
-4
Holders Change %
-4.71%
% of All Funds
1.81%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
28
Reduced
26
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
O
1
OppenheimerFunds
New York
|
$44.9M |
2 |
2
Dimensional Fund Advisors
Austin,
Texas
|
$5.85M |
3 |
3
Man Group
London,
United Kingdom
|
$5.64M |
4 |
4
Axa
Paris,
France
|
$8.61M |
5 |
5
Hudson Bay Capital Management
Stamford,
Connecticut
|
$3.32M |